Company News

Nature Review: The State of Antibody Therapeutics

Nature Review: The State of Antibody Therapeutics

A summary of a Nature Reviews Drug Discovery overview of antibody drug development, tracing 35 years of antibody engineering and the classes of formats now in clinical use.

What this service covers

  • Antibodies account for nearly one fifth of new FDA approvals
  • Evolution from murine to fully human formats
  • ADC, bispecific and nanobody classes
  • Manufacturing and immunogenicity considerations
  • Implications for target discovery workflows

Why work with Biogene

Library construction and screening are performed by the same team, using our All-Direct recombination chemistry. Every project is delivered with capacity, insert-size and positive-rate QC data, together with the raw records needed for publication.

Next step

Send us your sample type, species and research goal. Our scientists will confirm the technical route, the sample requirements and the turnaround time, and return a written quotation within one working day.

Nature Review: The State of Antibody Therapeutics
Back to list

Need a tailored protocol?

Tell us your research goal and sample type. Our scientists will design the workflow and quote for you.

Request a quote